Global Platinum based Cancer Drug Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Platinum based Cancer Drug Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
According to APO Research, The global Platinum based Cancer Drug market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Platinum based Cancer Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Platinum based Cancer Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Platinum based Cancer Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Platinum based Cancer Drug include Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug.
The Platinum based Cancer Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platinum based Cancer Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Platinum based Cancer Drug segment by Type

Cisplatin
Oxaliplatin
Carboplatin
Others
Platinum based Cancer Drug segment by Application

Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Platinum based Cancer Drug Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum based Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Platinum based Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum based Cancer Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Platinum based Cancer Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Platinum based Cancer Drug Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Platinum based Cancer Drug Sales Estimates and Forecasts (2019-2030)
1.3 Platinum based Cancer Drug Market by Type
1.3.1 Cisplatin
1.3.2 Oxaliplatin
1.3.3 Carboplatin
1.3.4 Others
1.4 Global Platinum based Cancer Drug Market Size by Type
1.4.1 Global Platinum based Cancer Drug Market Size Overview by Type (2019-2030)
1.4.2 Global Platinum based Cancer Drug Historic Market Size Review by Type (2019-2024)
1.4.3 Global Platinum based Cancer Drug Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Platinum based Cancer Drug Sales Breakdown by Type (2019-2024)
1.5.2 Europe Platinum based Cancer Drug Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Platinum based Cancer Drug Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Platinum based Cancer Drug Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Platinum based Cancer Drug Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Platinum based Cancer Drug Industry Trends
2.2 Platinum based Cancer Drug Industry Drivers
2.3 Platinum based Cancer Drug Industry Opportunities and Challenges
2.4 Platinum based Cancer Drug Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Platinum based Cancer Drug Revenue (2019-2024)
3.2 Global Top Players by Platinum based Cancer Drug Sales (2019-2024)
3.3 Global Top Players by Platinum based Cancer Drug Price (2019-2024)
3.4 Global Platinum based Cancer Drug Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Platinum based Cancer Drug Key Company Manufacturing Sites & Headquarters
3.6 Global Platinum based Cancer Drug Company, Product Type & Application
3.7 Global Platinum based Cancer Drug Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Platinum based Cancer Drug Market CR5 and HHI
3.8.2 Global Top 5 and 10 Platinum based Cancer Drug Players Market Share by Revenue in 2023
3.8.3 2023 Platinum based Cancer Drug Tier 1, Tier 2, and Tier 3
4 Platinum based Cancer Drug Regional Status and Outlook
4.1 Global Platinum based Cancer Drug Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Platinum based Cancer Drug Historic Market Size by Region
4.2.1 Global Platinum based Cancer Drug Sales in Volume by Region (2019-2024)
4.2.2 Global Platinum based Cancer Drug Sales in Value by Region (2019-2024)
4.2.3 Global Platinum based Cancer Drug Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Platinum based Cancer Drug Forecasted Market Size by Region
4.3.1 Global Platinum based Cancer Drug Sales in Volume by Region (2025-2030)
4.3.2 Global Platinum based Cancer Drug Sales in Value by Region (2025-2030)
4.3.3 Global Platinum based Cancer Drug Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Platinum based Cancer Drug by Application
5.1 Platinum based Cancer Drug Market by Application
5.1.1 Colorectal Cancer
5.1.2 Ovarian Cancer
5.1.3 Lung Cancer
5.1.4 Others
5.2 Global Platinum based Cancer Drug Market Size by Application
5.2.1 Global Platinum based Cancer Drug Market Size Overview by Application (2019-2030)
5.2.2 Global Platinum based Cancer Drug Historic Market Size Review by Application (2019-2024)
5.2.3 Global Platinum based Cancer Drug Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Platinum based Cancer Drug Sales Breakdown by Application (2019-2024)
5.3.2 Europe Platinum based Cancer Drug Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Platinum based Cancer Drug Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Platinum based Cancer Drug Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Platinum based Cancer Drug Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Platinum based Cancer Drug Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 Hengrui Medicine
6.2.1 Hengrui Medicine Comapny Information
6.2.2 Hengrui Medicine Business Overview
6.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hengrui Medicine Platinum based Cancer Drug Product Portfolio
6.2.5 Hengrui Medicine Recent Developments
6.3 ASK Pharma
6.3.1 ASK Pharma Comapny Information
6.3.2 ASK Pharma Business Overview
6.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ASK Pharma Platinum based Cancer Drug Product Portfolio
6.3.5 ASK Pharma Recent Developments
6.4 Yi Bai Pharmaceutical
6.4.1 Yi Bai Pharmaceutical Comapny Information
6.4.2 Yi Bai Pharmaceutical Business Overview
6.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio
6.4.5 Yi Bai Pharmaceutical Recent Developments
6.5 Qilu Pharmaceutical
6.5.1 Qilu Pharmaceutical Comapny Information
6.5.2 Qilu Pharmaceutical Business Overview
6.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio
6.5.5 Qilu Pharmaceutical Recent Developments
6.6 Teva
6.6.1 Teva Comapny Information
6.6.2 Teva Business Overview
6.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Platinum based Cancer Drug Product Portfolio
6.6.5 Teva Recent Developments
6.7 Pfizer
6.7.1 Pfizer Comapny Information
6.7.2 Pfizer Business Overview
6.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Pfizer Platinum based Cancer Drug Product Portfolio
6.7.5 Pfizer Recent Developments
6.8 Dr Reddy's Laboratories
6.8.1 Dr Reddy's Laboratories Comapny Information
6.8.2 Dr Reddy's Laboratories Business Overview
6.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio
6.8.5 Dr Reddy's Laboratories Recent Developments
6.9 Mylan
6.9.1 Mylan Comapny Information
6.9.2 Mylan Business Overview
6.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Platinum based Cancer Drug Product Portfolio
6.9.5 Mylan Recent Developments
6.10 Sun Pharma
6.10.1 Sun Pharma Comapny Information
6.10.2 Sun Pharma Business Overview
6.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Pharma Platinum based Cancer Drug Product Portfolio
6.10.5 Sun Pharma Recent Developments
6.11 Novartis
6.11.1 Novartis Comapny Information
6.11.2 Novartis Business Overview
6.11.3 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novartis Platinum based Cancer Drug Product Portfolio
6.11.5 Novartis Recent Developments
6.12 Debiopharm
6.12.1 Debiopharm Comapny Information
6.12.2 Debiopharm Business Overview
6.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Debiopharm Platinum based Cancer Drug Product Portfolio
6.12.5 Debiopharm Recent Developments
6.13 Accord Healthcare
6.13.1 Accord Healthcare Comapny Information
6.13.2 Accord Healthcare Business Overview
6.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Accord Healthcare Platinum based Cancer Drug Product Portfolio
6.13.5 Accord Healthcare Recent Developments
6.14 SK Chemicals
6.14.1 SK Chemicals Comapny Information
6.14.2 SK Chemicals Business Overview
6.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 SK Chemicals Platinum based Cancer Drug Product Portfolio
6.14.5 SK Chemicals Recent Developments
7 North America by Country
7.1 North America Platinum based Cancer Drug Sales by Country
7.1.1 North America Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Platinum based Cancer Drug Sales by Country (2019-2024)
7.1.3 North America Platinum based Cancer Drug Sales Forecast by Country (2025-2030)
7.2 North America Platinum based Cancer Drug Market Size by Country
7.2.1 North America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Platinum based Cancer Drug Market Size by Country (2019-2024)
7.2.3 North America Platinum based Cancer Drug Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Platinum based Cancer Drug Sales by Country
8.1.1 Europe Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Platinum based Cancer Drug Sales by Country (2019-2024)
8.1.3 Europe Platinum based Cancer Drug Sales Forecast by Country (2025-2030)
8.2 Europe Platinum based Cancer Drug Market Size by Country
8.2.1 Europe Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Platinum based Cancer Drug Market Size by Country (2019-2024)
8.2.3 Europe Platinum based Cancer Drug Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Platinum based Cancer Drug Sales by Country
9.1.1 Asia-Pacific Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Platinum based Cancer Drug Sales by Country (2019-2024)
9.1.3 Asia-Pacific Platinum based Cancer Drug Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Platinum based Cancer Drug Market Size by Country
9.2.1 Asia-Pacific Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Platinum based Cancer Drug Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Platinum based Cancer Drug Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Platinum based Cancer Drug Sales by Country
10.1.1 Latin America Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Platinum based Cancer Drug Sales by Country (2019-2024)
10.1.3 Latin America Platinum based Cancer Drug Sales Forecast by Country (2025-2030)
10.2 Latin America Platinum based Cancer Drug Market Size by Country
10.2.1 Latin America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Platinum based Cancer Drug Market Size by Country (2019-2024)
10.2.3 Latin America Platinum based Cancer Drug Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Platinum based Cancer Drug Sales by Country
11.1.1 Middle East and Africa Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Platinum based Cancer Drug Sales by Country (2019-2024)
11.1.3 Middle East and Africa Platinum based Cancer Drug Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Platinum based Cancer Drug Market Size by Country
11.2.1 Middle East and Africa Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Platinum based Cancer Drug Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Platinum based Cancer Drug Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Platinum based Cancer Drug Value Chain Analysis
12.1.1 Platinum based Cancer Drug Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Platinum based Cancer Drug Production Mode & Process
12.2 Platinum based Cancer Drug Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Platinum based Cancer Drug Distributors
12.2.3 Platinum based Cancer Drug Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings